GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Frequency Exchange Corp (TSXV:FREQ) » Definitions » Net Change in Cash

Frequency Exchange (TSXV:FREQ) Net Change in Cash : C$-1.13 Mil (TTM As of Sep. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Frequency Exchange Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Frequency Exchange's Net Change in Cash for the three months ended in Sep. 2023 was C$0.02 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Sep. 2023 was C$-1.13 Mil.

Frequency Exchange Net Change in Cash Historical Data

The historical data trend for Frequency Exchange's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Frequency Exchange Net Change in Cash Chart

Frequency Exchange Annual Data
Trend Oct20 Oct21 Dec22
Net Change in Cash
0.33 -0.04 0.79

Frequency Exchange Quarterly Data
Oct20 Jan21 Oct21 Jan22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Net Change in Cash Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.35 -0.46 -0.39 -0.30 0.02

Frequency Exchange Net Change in Cash Calculation

Frequency Exchange's Net Change in Cash for the fiscal year that ended in Dec. 2022 is calculated as

Net Change in Cash= Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=-1.499+-0.15+2.434+0
=0.79

Frequency Exchange's Net Change in Cash for the quarter that ended in Sep. 2023

Net Change in Cash=Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=-0.287+0+0.306+0
=0.02

Net Change in Cash for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-1.13 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequency Exchange Net Change in Cash Related Terms

Thank you for viewing the detailed overview of Frequency Exchange's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Frequency Exchange (TSXV:FREQ) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Frequency Exchange Corp (TSXV:FREQ) » Definitions » Net Change in Cash
Comparable Companies
XCNQ:PMED TSXV:THRM XCNQ:IME TSXV:TEST.H TSXV:VER.H XCNQ:ASTI TSXV:MDX TSX:TMD TSXV:SGMD TSXV:NGMD ABT SYK MDT BSX SZSE:300760 EW DXCM ZBH STE XAMS:PHIA
Traded in Other Exchanges
N/A
Address
1055 West Georgia Street, Suite 2050, PO Box 11121, Vancouver, BC, CAN, V6E 3P3
Website
https://www.frequencyexchangecorp.com
Frequency Exchange Corp is focused on the development and global commercialization of a wearable Frequency Delivery System providing specialized programs designed for health and wellness as well as performance enhancement.
Executives
Stephen Davis 10% Security Holder, Director, Senior Officer

Frequency Exchange (TSXV:FREQ) Headlines

From GuruFocus

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating Frequency Therapeutics, Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors

By PRNewswire PRNewswire • 11-29-2022

FREQUENCY THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Frequency Therapeutics, Inc. - FREQ

By Business Wire • 10-06-2023

Frequency Therapeutics Announces First Patient Dosed in Phase 1b Study of FX-345, the Company's Second Therapeutic Candidate for Sensorineural Hearing Loss

By Business Wire Business Wire • 12-15-2022

Frequency Therapeutics Provides Business Updates and Reports Fourth Quarter and Full Year 2021 Financial Results

By Business Wire Business Wire • 03-15-2022

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AJX, DEN, FREQ, NLTX

By PRNewswire • 08-01-2023

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AAIC, BG, DEN, FREQ

By PRNewswire • 07-26-2023

Frequency Therapeutics Announces Formation of Clinical Advisory Board for Remyelination in Multiple Sclerosis Program

By Business Wire Business Wire • 12-19-2022

Frequency Therapeutics Provides Business Updates and First Quarter 2023 Financial Results

By Business Wire Business Wire • 05-12-2023

SHAREHOLDER ALERT: The M&A Class Action Firm Continues Investigating the Merger -- FREQ, BG, EMAN, DEN

By Marketwired • 07-31-2023

Gainey McKenna & Egleston Investigates The Officers And Directors Of Frequency Therapeutics, Inc. (FREQ)

By GuruFocusNews GuruFocusNews • 07-08-2022